Semaglutide body dysmorphia affects 15–30% of rapid weight loss patients. Recognize symptoms early and implement structured mental health support

Most patients lose 4–6 pounds in month one on semaglutide — appetite suppression starts within 72 hours, but meaningful fat loss requires 8–12 weeks at

Semaglutide can trigger or worsen eating disorders through appetite suppression and delayed gastric emptying — screening before prescription is critical.

Semaglutide 1 year results show 15–20% mean body weight loss with sustained metabolic benefits, but maintenance depends on continued therapy and lifestyle

Semaglutide delivers 15-20% body weight reduction after one year in clinical trials. Here’s what real-world results look like and what affects outcomes.

Semaglutide typically produces 12-15% body weight reduction at six months when combined with dietary structure and dose titration — here’s the clinical

The semaglutide highest dose is 2.4mg weekly for weight loss, titrated over 16–20 weeks. Higher doses increase GI side effects without proportional

Semaglutide rebound hunger occurs when GLP-1 receptor downregulation and ghrelin rebound overwhelm satiety signals after stopping treatment or missing

Semaglutide disrupts stress eating by reducing cortisol-triggered reward signaling and extending satiety duration—not by eliminating emotions, but by